18Loop has deployed 25 Oculus VR headsets to kids with cancer and we continue to receive results and feedback. "Our focus has been on Virtual Stress Management, which we deliver through the deployment of the Tripp platform," says 18Loop CEO Greg Tarnacki. "What has been encouraging is the benefit that gaming provides by stimulating physical activity and promoting recovery in ways that we could not have forecast at the beginning of our study." Several oncologists have reported that exercise games are a great asset and that our VR is a benefit. We have footage of several kids playing Beat Saber and it is great to see them having fun while they recover. As a part of our results gathering, we are identifying the games and environments that 18Loop kids utilize.
18Loop has focused on mood through stimulating meditation, but we have discovered that VR immersion helps more than half of our research participants to manage pain as well. There are VR technologies that focus on distraction from pain, and in future research we hope to realize a greater impact as we target our technology deployment in that area. Statistics indicate that VR can outperform morphine in certain studies. VR isn't addictive and also provides a residual impact that lingers after immersion. Some experts forecast that VR treatment will be ubiquitous in future hospital environments.
As we move forward, 18Loop will continue to test the impact of VR in a fully immersive environment. We expect to additionally examine the efficacy of Augmented Reality (AR) through the Tripp AR platform and beyond. The future rests on an Artificial Intelligence backbone, with results being delivered through Spatial Computing (AR/VR), Natural Language Processing (NLP) and Robotics. We are excited to have reach in these areas and we look forward to your support for our research and deployment to our kids. Please donate today!
This summer, 18Loop is focusing on several new research initiatives that will help our kids with cancer to tolerate treatment, recover and thrive. Our Joint Experimental Intervention Research Study (JEIRS) with the American Childhood Cancer Organization (ACCO) currently has a full cohort of 25 participants. We are receiving great qualitative feedback from the kids and families in the study. As 18Loop prepares to launch a second JEIRS cohort, our eyes are on hardware reusability and quantitative measurement. We currently have a backlog of 19 children waiting for our VR and we expect to deliver in the November timeframe.
18Loop is currently exploring other applications for our VR with the ACCO and Texas Children's Hospital. We are at the preliminary stages of partnering in further research focused on hospice care for DIPG. This effort is important to us, as it speaks directly to our mission to increase treatment tolerance and comfort kids struggling with the disease. 18Loop is happy to be engaged with the ACCO, AppliedVR and other partners as we continue to work toward launching our new research. Based on our early results, we are confident that VR will make a difference and believe that the only questions depend on how significant the benefit will be.
Our research tells us that 16,000 kids get diagnosed with pediatric cancer every year, and you can make a difference by donating to us. As of August, all donations are being directly channeled to the purchase of new VR technology for our kids. 18Loop is a board run organization without any current salaries. Our goal is to deliver the VR technology to as many kids with cancer as we can. As we report the benefits, we can build consensus around making VR a necessary component of treatment. Please donate and help 18Loop do this!
We are excited to announce that in May, with the help of the American Childhood Cancer Organization (ACCO), 18Loop more than doubled the number of kids with cancer in the the Joint Experimental Intervention Research Study (JEIRS). So far, our survey data has indicated that all of our kids report doing better in the hospital with VR. We are making a great impact and are looking forward to gathering more data. Future metrics include quantitative monitoring of the VR experiences that impact our kids, measurement of breathing and potential brain wave analysis. 18Loop has open lines of communication to the very best in therapeutic VR and our goal is to offer it safely and effectively.
18Loop's current focus is on scaling JEIRS, investigating new technologies and fundraising. Currently, all of our kids keep their headsets. This is wonderful for their experience (and the experience of their families), but it is a costly solution. We are closely examining new and different approaches that would continue to deliver the benefit of VR but with better paths to scale and technology reuse when appropriate. Please help us to further our mission!
Our 18Loop star kid of the month is Molly, who just received her Oculus headset. Molly is 19 and is a two time cancer fighter. She appeared on ABC's The View the day she received her headset. Molly is an inspiration and drives us to continue to reach out to teens like her. Good luck with the VR Molly!
18Loop is proud to announce that we have won an honorable mention in Fast Company's World Changing Ideas 2021. Check out our Press Release HERE. This recognition will help us to raise funds and to scale our growing research study. We are shipping new Oculus Quest 2 headsets in May, and the American Childhood Cancer Organization (ACCO) has already received the initial technology. Our focus throughout the rest of the year will be on scaling our footprint of deployed headsets, gathering qualitative and quantitative data and driving fundraising to support our mission. We are excited to be engaged and hope to earn your support!
18Loop has received feedback this month from the field and is proud to announce that we have discovered another great application of VR for our kids with cancer. Miles, an ACCO child, sent us video of himself playing Beat Saber. Miles' mom told us that his doctors thought that the physical activity of the game helped him to flush the chemotherapy drug out of his system after treatment, providing a physical stimulus that was hard to achieve while confined in the hospital. Get better Miles, and keep using VR!
In the coming months, we will ship many more VR headsets and continue to grow our relationship with the ACCO. We are excited that we are generating interest from those who treat and cope with childhood cancer as well as from those who work in the field of VR. 18Loop is worthy of support not only because we are unique in addressing the mood of our kids, but also because we provide Oculus VR for free to our kids and families. Every kid gets a VR headset, and families are encouraged to enjoy them for gaming, communication and stress management together. 18Loop is a 501(c)(3) nonprofit. Help us help our kids!
18Loop is happy to announce that Phase II of our Joint Experimental Intervention Research Study (JEIRS) with the American Childhood Cancer Organization (ACCO) has been funded by Servier Pharmaceuticals. Servier is a partner of the ACCO and is helping the 18Loop team to support ACCO kids in the fight against pediatric cancer. It has been a pleasure working with Wendy Poage, Servier's Head of Patient Advocacy and Engagement and Tara Brown, Patient Engagement. We are currently awaiting the Servier funds, which when received will allow us to purchase technology for our research. Our wider reach will contribute to a better assessment of our impact. In the teen target group for JEIRS, we feel confident that the VR is being well received and tolerated. Therefore, we are looking not to only prove the efficacy of the intervention, but to prove it to be superior to other alternatives. 18Loop has been effective for mood enhancement, communication and entertainment, and has even made an impact on pain. So far, we are doing well, and with Servier's support, we can carry out further testing and move toward our goal of wider distribution.
April is an exciting time for 18Loop! Please stay tuned for more announcements about partnerships to reach our target teen cancer demographic and recognition for our Virtual Reality approach.
When pediatric cancer patient Elizabeth first tried Virtual Reality (VR), she exclaimed that it was “amazing and exciting.” She didn’t realize it at first, but VR would prove to be an aid in the hospital for her and her fellow study participants. Elizabeth is the first of seven teens to test VR in 18Loop and the American Childhood Cancer Organization’s (ACCO) Joint Experimental Intervention Research Study (JEIRS). Together, 18Loop and the ACCO are seeking to prove that VR is safe and effective in aiding kids with cancer in their treatment and recovery. The research team is working closely with Tripp, a startup xR company that delivers Virtual Stress Management in a comforting high tech meditative package. This week, 18Loop and the ACCO are sharing early data from JEIRS, and it looks like they are on track. Tripp and VR as a whole are an early success with the kids.
One of the key data points derived from the survey sent to the first seven 18Loop/ACCO JEIRS kids was that 100% of them felt VR made for a better hospital stay. Six of seven felt that Tripp’s environment improved their mood and six of seven also felt that VR as a whole made them better off. More than half of the study participants felt that Tripp helped with pain, and all used the software at least once a week. Luke, an ACCO kid, pointed out that Tripp was effective, but that VR was also a big help in fighting boredom in the hospital. It provides access to another world that the kids love to explore.
With VR, you can get a multi-player effect, and family can join in. Successful family intervention is prized in the Palliative Care community and VR offers an opportunity to reach families as a whole. The 18Loop/ACCO kids (including mothers and siblings) used a variety of VR games successfully, all while maintaining a regimen with Tripp to affect mood. These preliminary metrics and observations from our kids are encouraging, albeit from a small sample size. 18Loop plans to distribute fifteen total VR headsets with access to Tripp in the first phase of JEIRS. A second phase is currently being planned and funded, with an eye on younger participants.
18Loop is grateful for its partnership with the ACCO, and credits their organization for providing access and joint management oversight for JEIRS. Ruth Hoffman, ACCO CEO, has had many ideas about the application of VR and has given 18Loop the green light to implement them. Blair Cresawn, 18Loop’s day to day contact at the ACCO, has tirelessly worked with 18Loop/ACCO kids to ensure that the technology is being received and reviewed effectively. Our calls with JEIRS kids have been lively and informative. Once we connect through the ACCO, we feel a sense of larger community within which we have begun to support Advocacy efforts alongside our partners.
It is expected that the initial research done on VR can eventually lead to technology distribution to a larger portion of the 16,000 kids that get diagnosed with pediatric cancer each year. Tripp has contributed to 18Loop’s work as well, donating five Oculus headsets for testing and offering support with technology monitoring and adoption. We are happy to work with CEO Nanea Reeves, whose generosity and leadership have benefitted us greatly. Please take a look at the preliminary 18Loop/ACCO JEIRS study results below and support us in helping kids with cancer.
2021 has been a wonderful year for 18Loop and our kids with cancer. All of us are grateful that although the pandemic is still not controlled, life is moving ahead. A key focus area for the 18Loop team in 2021 is scientific research. In order to effectively distribute our VR solution, it was necessary to test its safety and efficacy. We are doing this in conjunction with the American Childhood Cancer Organization (ACCO) and Tripp, the company that supplies our Virtual Stress Management Environments. Our Joint Experimental Intervention Research Study (JEIRS) launched in late 2020, and we are already gathering qualitative data and preparing to collect quantitative metrics from the deployed headsets.
The first phase of JEIRS is funded and as of this post, there were eight teens who have either received VR headsets or are expecting them soon. Our team will measure 15 children in total in this first phase, all of whom are teenagers. There is a plan for a subsequent phase that will test Tripp on younger cancer patients. Our early data indicates that Tripp is beneficial in both the inpatient hospital environment and the outpatient home environment. VR Stress Management software like Calm and Focus from Tripp ease the nerves and center our cancer teens. They also fight boredom in the cancer ward by utilizing VR for games and information. In future family interventions, we may connect families virtually even when they can't meet in person. 18Loop's overarching goal is to improve survival rates by helping our kids tolerate treatment, recover and thrive. We hope that VR for kids with cancer becomes a non-narcotic solution for pain and helps to combat side effects in a similar way that drugs like odansetron do now.
This Spring, 18Loop is expanding our research to the cancer center. We are at the beginning of an Institutional Review Board (IRB) process that will vet our technology and approach, allowing our team to launch a new research initiative that will expand on our work with the ACCO. Tripp will help us with technology monitoring and by bringing their vast experience working in hospitals to our effort. Together with oncologists, palliative care physicians, 18Loop team members and technologists, we will seek to publish research on our impact and mission. This will allow us to confidently advocate for VR for the pediatric oncology population, with the confidence that our approach is overwhelmingly beneficial. Only then can we begin the process of widely distributing VR technology to as many of the 16,000 children diagnosed with cancer each year that can benefit like our early study participants. Please support us in our efforts!
18Loop is very excited about our signature program Virtual Comfort. We are beginning the distribution of Oculus VR headsets to children with cancer. This distribution is being facilitated by the American Childhood Cancer Organization (ACCO). Initially, we planned to deploy mobile VR technology, but our testing with the ACCO drove us to look further. Oculus affords us the best optics, the ability to adjust pupillary distance and the capacity to run custom environments. For Virtual Comfort, ACCO kids are testing environments coded by Tripp, which combine a gaming sensibility with meditation and computer science. We believe that this will elevate the mood of our children and help with pain as well.
Our first Virtual Comfort child Elizabeth touched base with me a few weeks ago, and her report couldn't have been more positive. Our VR had improved her mood, and it was being used by her little brother as well. We didn't initially anticipate that Virtual Comfort would impact families beyond the patient level, but Elizabeth and her brother proved us wrong. 18Loop expects to deploy 10 Oculus headsets by Q1 2021, with our sights on 50 headsets by midyear. We will need help fundraising to support the growth of the program, but we are already receiving help. Nanea Reeves, CEO of Tripp, sent 18Loop 5 Oculus headsets last week. This contributed to success in achieving our initial goal with the ACCO. Nanea is a great partner, and Tripp is a wonderful company!
In the coming months, 18Loop will scale our deployment of VR through the ACCO and will also begin exploring relationships with cancer centers. The goal is to execute a Case Study derived from specific quantitative metrics gathered in the hospital. We are currently collaborating with our team as we work to develop a protocol and explore relationships on the medical front. As we progress, we will never forget the relationship we developed with Elizabeth, as her family is vital to our early success. We look forward to 2021 becoming the year of 18Loop's growth in impact. You will remember 18Loop and especially Elizabeth, as she is the cancer warrior pictured on the front page of 18Loop.org. Thanks Elizabeth!
Advocacy and Awareness is a mission of 18Loop. We are dedicated not just to deploy Virtual Reality (VR) in the fight against pediatric cancer, but to inform and encourage others to do so as well. 18Loop is doing this by getting our message out on Social Media, by planning to address future events and by collaborating with our partners.
I am friendly with a very capable Solutions Architect in the telecom industry who is up to date on most modern technology, and when we spoke the other day he was confused a bit by my VR/Spatial Computing message. He didn't have a window into the future and was unaware of the coming changes in the industry. If a top cloud professional didn't know, how are cancer families supposed to know? Smart minds are beginning to talk about specialized VR positions emerging in hospitals to administer VR environments to recovering patients. These workers will be called "Virtualists", but we likely won't receive care from them for a few years. That's were 18Loop comes in.
2021 will be an exciting year for 18Loop. We will launch our cancer center case studies, working hard to gather quantitative metrics on our unique solution. This will drive grant solicitation, fundraising with high wealth donors and the delivery of results to the individuals that support us day to day. Our academic achievements will drive our altruistic efforts and sustain our wider mission. We plan to address the HIMSS (Health Information Management and Systems Society) conference in August 2021 and are exploring avenues to spread the word on 18Loop as soon as the pandemic allows. FutureHealth.global has nominated us for an award (Best Digital Technological Innovation), and we hope to attend the event and collect a victory!
Spatial Computing is the name that some technologists give to the ubiquitous eventual world of xR. For those who don't know, xR refers to VR, AR and MR, or Virtual Reality, Augmented Reality and Mixed Reality. VR uses a headset to put you in a world that is entirely computer generated. AR allows you to view your own real environment (through glasses or contacts) and it adds (or augments) that environment with computer generated graphics or holograms. These graphics are often static. MR does what AR does, but allows for the graphics to interact with other objects in the environment. At 18Loop, we are initially interested in the VR aspect of Spatial Computing. We feel that the current level of technology is more than sufficient to make a huge impact. We are now deploying the Oculus Quest, and as is often the case, new technology (the Quest 2) has emerged. 18Loop is excited to deploy the Quest 2 soon with Tripp environments. We believe that this new (and very real) solution will help kids with cancer tolerate treatment, recover and thrive.
Based on our resources, we think xR will play a huge role in society in the coming decade and beyond. The top tech companies are all investing in the development of this technology and what is currently available can no longer be ignored. By 2025, we'll see AR glasses becoming more prevalent. The initial adopters will be thought of the same way early iPhone adopters were: "your phone is nice to have, but I don't need it!". In similar fashion, in 2030 even Grandma will be using xR.
18Loop is excited about the times we live in. VR has been proven to have an efficacy greater than morphine in treating pain. Our partners at Tripp offer a Virtual Stress Management solution that is not yet an authorized therapy, but combines gaming, meditation and computer science to scientifically improve mood. Stick with us to watch and read about the results of our Pilot with the American Childhood Cancer Organization! Spatial Computing is at an early age, but it's here to stay. Help us help our kids fight cancer and win.